SS Healthcare (Taiwan) Performance
| 4198 Stock | TWD 32.20 1.50 4.45% |
The entity owns a Beta (Systematic Risk) of -0.22, which indicates not very significant fluctuations relative to the market. As returns on the market increase, returns on owning SS Healthcare are expected to decrease at a much lower rate. During the bear market, SS Healthcare is likely to outperform the market. At this point, SS Healthcare Holding has a negative expected return of -0.0845%. Please make sure to validate SS Healthcare's coefficient of variation, jensen alpha, and the relationship between the mean deviation and standard deviation , to decide if SS Healthcare Holding performance from the past will be repeated at some future date.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days SS Healthcare Holding has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, SS Healthcare is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors. ...more
4198 |
SS Healthcare Relative Risk vs. Return Landscape
If you would invest 3,520 in SS Healthcare Holding on August 30, 2024 and sell it today you would lose (300.00) from holding SS Healthcare Holding or give up 8.52% of portfolio value over 90 days. SS Healthcare Holding is generating negative expected returns and assumes 3.4941% volatility on return distribution over the 90 days horizon. Simply put, 31% of stocks are less volatile than 4198, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
SS Healthcare Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for SS Healthcare's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as SS Healthcare Holding, and traders can use it to determine the average amount a SS Healthcare's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0242
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 4198 |
Estimated Market Risk
| 3.49 actual daily | 31 69% of assets are more volatile |
Expected Return
| -0.08 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.02 actual daily | 0 Most of other assets perform better |
Based on monthly moving average SS Healthcare is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of SS Healthcare by adding SS Healthcare to a well-diversified portfolio.
SS Healthcare Fundamentals Growth
4198 Stock prices reflect investors' perceptions of the future prospects and financial health of SS Healthcare, and SS Healthcare fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on 4198 Stock performance.
| EBITDA | (177.78 M) | |||
| Cash And Equivalents | 120.22 M | |||
| Cash Per Share | 2.83 X | |||
| Total Debt | 139.82 M | |||
| Debt To Equity | 66.80 % | |||
| Book Value Per Share | 4.92 X | |||
| Cash Flow From Operations | (147.41 M) | |||
| Earnings Per Share | (4.50) X | |||
About SS Healthcare Performance
Evaluating SS Healthcare's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if SS Healthcare has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if SS Healthcare has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Swissray Global Healthcare Holding Ltd., together with its subsidiaries, primarily focuses on the research and development, manufacture, and sale of medical imaging devices. Swissray Global Healthcare Holding Ltd. was founded in 1988 and is headquartered in Taipei City, Taiwan. SWISSRAY GLOBAL operates under Medical Devices classification in Taiwan and is traded on Taiwan OTC Exchange.Things to note about SS Healthcare Holding performance evaluation
Checking the ongoing alerts about SS Healthcare for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for SS Healthcare Holding help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| SS Healthcare generated a negative expected return over the last 90 days | |
| SS Healthcare has high historical volatility and very poor performance | |
| SS Healthcare has high likelihood to experience some financial distress in the next 2 years | |
| The company has NT$139.82 Million in debt which may indicate that it relies heavily on debt financing | |
| Net Loss for the year was (191.49 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| SS Healthcare Holding has accumulated about 120.22 M in cash with (147.41 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.83. |
- Analyzing SS Healthcare's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether SS Healthcare's stock is overvalued or undervalued compared to its peers.
- Examining SS Healthcare's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating SS Healthcare's management team can have a significant impact on its success or failure. Reviewing the track record and experience of SS Healthcare's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of SS Healthcare's stock. These opinions can provide insight into SS Healthcare's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for 4198 Stock Analysis
When running SS Healthcare's price analysis, check to measure SS Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SS Healthcare is operating at the current time. Most of SS Healthcare's value examination focuses on studying past and present price action to predict the probability of SS Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SS Healthcare's price. Additionally, you may evaluate how the addition of SS Healthcare to your portfolios can decrease your overall portfolio volatility.